ARCHIVES

Agency Expands Gleevec Label To Include Rare GIST Subset

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Lasker Official Urges Congressional Support Of NCI Bypass Budget

April 20, 1990

NCI Study Fails To Support Finding Of Excess Cancer In Utah Nuclear Fallout Areas

January 23, 1987

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

Presidential Candidates Promise Increases In Funding For Cancer Research, Prevention.

September 14, 2007

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

NCI To Recompete Smokeless Tobaccos RFA as PA

January 24, 1986